STOKE THERAPEUTICS INC (STOK:NASDAQ)
$29.23 -0.08 (-0.2729%)
Analysed STOKE THERAPEUTICS INC (STOK:NASDAQ) News Sources
Stoke Therapeutics Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
Stoke Therapeutics, Inc. (NASDAQ:STOK) Analysts Are Pretty Bullish On The Stock After Recent Results
11-05-2026
yahoo.com
Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates
01-06-2026
yahoo.com
Stoke Therapeutics (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
04-06-2026
yahoo.com
4 Biotech Stocks Investors Should Watch in 2026
05-06-2026
yahoo.com
Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
30-06-2026
yahoo.com
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
13-07-2026
yahoo.com
Ionis Begins Dosing in Phase I/II Dravet Syndrome Study
14-07-2026
yahoo.com
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16-07-2026
yahoo.com
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
27-07-2026
yahoo.com
What is the current price of STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The current price of STOKE THERAPEUTICS INC (STOK:NASDAQ) is $29.23.
STOKE THERAPEUTICS INC (STOK:NASDAQ) absolute price change since previous trading day?
The absolute price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is $-0.08.
STOKE THERAPEUTICS INC (STOK:NASDAQ) percentage price change since previous trading day?
The percentage price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is -0.2729%.
What is the most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ) is .
SEC-8K** Filing Available For STOKE THERAPEUTICS INC (STOK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.